These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32178572)

  • 1.
    Wang J; Fan J; Gao W; Wu Y; Zhao Q; Chen B; Ding Y; Wen S; Nan X; Wang B
    Stem Cells Dev; 2020 Jun; 29(12):774-785. PubMed ID: 32178572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
    Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
    Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA FOXD2-AS1 enhances chemotherapeutic resistance of laryngeal squamous cell carcinoma via STAT3 activation.
    Li R; Chen S; Zhan J; Li X; Liu W; Sheng X; Lu Z; Zhong R; Chen L; Luo X; Hu Y; Ouyang Y; Liu T; Zhang Q; Zhang S
    Cell Death Dis; 2020 Jan; 11(1):41. PubMed ID: 31959918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α2δ1 may be a potential marker for cancer stem cell in laryngeal squamous cell carcinoma.
    Huang C; Li Y; Zhao W; Zhang A; Lu C; Wang Z; Liu L
    Cancer Biomark; 2019; 24(1):97-107. PubMed ID: 30475757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLOD2 contributes to drug resistance in laryngeal cancer by promoting cancer stem cell-like characteristics.
    Sheng X; Li Y; Li Y; Liu W; Lu Z; Zhan J; Xu M; Chen L; Luo X; Cai G; Zhang S
    BMC Cancer; 2019 Aug; 19(1):840. PubMed ID: 31455288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HAX-1 by miR-125a reverses cisplatin resistance in laryngeal cancer stem cells.
    Liu J; Tang Q; Li S; Yang X
    Oncotarget; 2016 Dec; 7(52):86446-86456. PubMed ID: 27880721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiproliferative efficacies but minor drug transporter inducing effects of paclitaxel, cisplatin, or 5-fluorouracil in a murine xenograft model for head and neck squamous cell carcinoma.
    Theile D; Gal Z; Warta R; Rigalli JP; Lahrmann B; Grabe N; Herold-Mende C; Dyckhoff G; Weiss J
    Cancer Biol Ther; 2014 Apr; 15(4):436-42. PubMed ID: 24448417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma.
    Yang JP; Liu Y; Zhong W; Yu D; Wen LJ; Jin CS
    Chin Med J (Engl); 2011 Apr; 124(7):1055-60. PubMed ID: 21542968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD10 as a novel marker of therapeutic resistance and cancer stem cells in head and neck squamous cell carcinoma.
    Fukusumi T; Ishii H; Konno M; Yasui T; Nakahara S; Takenaka Y; Yamamoto Y; Nishikawa S; Kano Y; Ogawa H; Hasegawa S; Hamabe A; Haraguchi N; Doki Y; Mori M; Inohara H
    Br J Cancer; 2014 Jul; 111(3):506-14. PubMed ID: 24874475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PFKL promotes cell viability and glycolysis and inhibits cisplatin chemosensitivity of laryngeal squamous cell carcinoma.
    Wang P; Ye Y; Chen Z; Li R; Hou G; Liu Z
    Biochem Biophys Res Commun; 2024 Oct; 730():150366. PubMed ID: 38991254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition.
    Kulsum S; Sudheendra HV; Pandian R; Ravindra DR; Siddappa G; R N; Chevour P; Ramachandran B; Sagar M; Jayaprakash A; Mehta A; Kekatpure V; Hedne N; Kuriakose MA; Suresh A
    Mol Carcinog; 2017 Feb; 56(2):694-711. PubMed ID: 27380877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced cancer stem cell properties of a mitotically quiescent subpopulation of p75NTR-positive cells in esophageal squamous cell carcinoma.
    Kojima H; Okumura T; Yamaguchi T; Miwa T; Shimada Y; Nagata T
    Int J Oncol; 2017 Jul; 51(1):49-62. PubMed ID: 28534989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-canonical RNA-binding protein ANXA11 regulates microRNA resorting into small extracellular vesicles to mediate cisplatin resistance.
    Zhang Y; Huang Q; Shen Y; Ren H; Wu C; Zhou L
    FASEB J; 2024 Sep; 38(17):e70048. PubMed ID: 39259536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.
    Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY
    Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological inhibition of MYC to mitigate chemoresistance in preclinical models of squamous cell carcinoma.
    Liu S; Qin Z; Mao Y; Wang N; Zhang W; Wang Y; Chen Y; Jia L; Peng X
    Theranostics; 2024; 14(2):622-639. PubMed ID: 38169606
    [No Abstract]   [Full Text] [Related]  

  • 16. Ly6D facilitates chemoresistance in laryngeal squamous cell carcinoma through miR-509/β-catenin signaling pathway.
    Wang J; Sheng N; Li Y; Fan Y; Nan X; Fu R
    Am J Cancer Res; 2023; 13(5):2155-2171. PubMed ID: 37293155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor of DNA binding 2 is a novel therapeutic target for stemness of head and neck squamous cell carcinoma.
    Bae WJ; Koo BS; Lee SH; Kim JM; Rho YS; Lim JY; Moon JH; Cho JH; Lim YC
    Br J Cancer; 2017 Dec; 117(12):1810-1818. PubMed ID: 29096401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting BMI1
    Chen D; Wu M; Li Y; Chang I; Yuan Q; Ekimyan-Salvo M; Deng P; Yu B; Yu Y; Dong J; Szymanski JM; Ramadoss S; Li J; Wang CY
    Cell Stem Cell; 2017 May; 20(5):621-634.e6. PubMed ID: 28285905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
    Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
    Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profile of stem cell markers and ABC transporters in 5-fluorouracil resistant Hep-2 cells.
    Duz MB; Karatas OF
    Mol Biol Rep; 2020 Jul; 47(7):5431-5438. PubMed ID: 32627138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.